- Mitochondrial Mechanisms in Diabetic Cardiomyopathy
-
Gollmer J, Zirlik A, Bugger H
- KMID: 2470953
- Diabetes Metab J.
- 2020 Feb;44(1):33-53.
- doi: 10.4093/dmj.2019.0185
Mitochondrial medicine is increasingly discussed as a promising therapeutic approach, given that mitochondrial defects are thought to contribute to many prevalent diseases and their complications. In individuals with diabetes mellitus... -
- CITED
-
- Close
- SHARE
-
- Close
- Established and Emerging Mechanisms of Diabetic Cardiomyopathy
-
Gollmer J, Zirlik A, Bugger H
- KMID: 2447754
- J Lipid Atheroscler.
- 2019 May;8(1):26-47.
- doi: 10.12997/jla.2019.8.1.26
Diabetes mellitus increases the risk for the development of heart failure even in the absence of coronary artery disease and hypertension, a cardiac entity termed diabetic cardiomyopathy (DC). Clinically, DC... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice
-
Tarkhnishvili A, Koentges C, Pfeil K, Gollmer J, Byrne NJ, Vosko I, Lueg J, Vogelbacher L, Birkle S, Tang S, Mwinyella TBN, Hoffmann MM, Odening KE, Michel NA, Wolf D, Stachon P, Hilgendorf I, Wallner M, Ljubojevic-Holzer S, Lewinski Dv, Rainer P, Sedej S, Sourij H, Bode C, Zirlik A, Bugger H
- KMID: 2531858
- J Lipid Atheroscler.
- 2022 May;11(2):161-177.
- doi: 10.12997/jla.2022.11.2.161
Objective: Impaired cardiac efficiency is a hallmark of diabetic cardiomyopathy in models of type 2 diabetes. Adiponectin receptor 1 (AdipoR1) deficiency impairs cardiac efficiency in non-diabetic mice, suggesting that hypoadiponectinemia... -
- CITED
-
- Close
- SHARE
-
- Close
